Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

Overview of attention for article published in Critical Care, August 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#35 of 6,609)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 44 news outlets
policy: 1 policy source
twitter: 3 X users

patent: 4 patents
facebook: 2 Facebook pages

Citations

dimensions_citation: 59 Dimensions

Readers on

mendeley: 161 Mendeley

Summary News Policy documents X Patents Facebook Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Therapeutics and COVID-19: living guideline, 20 November 2020

Cited by World Health Organization on 19 Nov 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Therapeutics and COVID-19: living guideline, 20 November 2020

Cited by World Health Organization on 01 Jan 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.